Literature DB >> 31428777

Regulation of Macrophage Foam Cell Formation During Nitrogen Mustard (NM)-Induced Pulmonary Fibrosis by Lung Lipids.

Alessandro Venosa1, Ley Cody Smith1, Alexa Murray1, Tanvi Banota1, Andrew J Gow1, Jeffrey D Laskin2, Debra L Laskin1.   

Abstract

Nitrogen mustard (NM) is a vesicant known to target the lung, causing acute injury which progresses to fibrosis. Evidence suggests that activated macrophages contribute to the pathologic response to NM. In these studies, we analyzed the role of lung lipids generated following NM exposure on macrophage activation and phenotype. Treatment of rats with NM (0.125 mg/kg, i.t.) resulted in a time-related increase in enlarged vacuolated macrophages in the lung. At 28 days postexposure, macrophages stained positively for Oil Red O, a marker of neutral lipids. This was correlated with an accumulation of oxidized phospholipids in lung macrophages and epithelial cells and increases in bronchoalveolar lavage fluid (BAL) phospholipids and cholesterol. RNA-sequencing and immunohistochemical analysis revealed that lipid handling pathways under the control of the transcription factors liver-X receptor (LXR), farnesoid-X receptor (FXR), peroxisome proliferator-activated receptor (PPAR)-ɣ, and sterol regulatory element-binding protein (SREBP) were significantly altered following NM exposure. Whereas at 1-3 days post NM, FXR and the downstream oxidized low-density lipoprotein receptor, Cd36, were increased, Lxr and the lipid efflux transporters, Abca1 and Abcg1, were reduced. Treatment of naïve lung macrophages with phospholipid and cholesterol enriched large aggregate fractions of BAL prepared 3 days after NM exposure resulted in upregulation of Nos2 and Ptgs2, markers of proinflammatory activation, whereas large aggregate fractions prepared 28 days post NM upregulated expression of the anti-inflammatory markers, Il10, Cd163, and Cx3cr1, and induced the formation of lipid-laden foamy macrophages. These data suggest that NM-induced alterations in lipid handling and metabolism drive macrophage foam cell formation, potentially contributing to the development of pulmonary fibrosis.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  foam cells; lipids; macrophages; mustards; pulmonary fibrosis; vesicants

Mesh:

Substances:

Year:  2019        PMID: 31428777      PMCID: PMC6876262          DOI: 10.1093/toxsci/kfz187

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  85 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  Expression of fatty acid-binding protein 4/aP2 is correlated with plaque instability in carotid atherosclerosis.

Authors:  H E Agardh; L Folkersen; J Ekstrand; D Marcus; J Swedenborg; U Hedin; A Gabrielsen; G Paulsson-Berne
Journal:  J Intern Med       Date:  2010-11-14       Impact factor: 8.989

3.  Effects of FXR in foam-cell formation and atherosclerosis development.

Authors:  Grace L Guo; Silvia Santamarina-Fojo; Taro E Akiyama; Marcelo J A Amar; Beverly J Paigen; Bryan Brewer; Frank J Gonzalez
Journal:  Biochim Biophys Acta       Date:  2006-10-14

4.  Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma.

Authors:  Serena Ghisletti; Wendy Huang; Sumito Ogawa; Gabriel Pascual; Mu-En Lin; Timothy M Willson; Michael G Rosenfeld; Christopher K Glass
Journal:  Mol Cell       Date:  2007-01-12       Impact factor: 17.970

Review 5.  Foam cell formation: A new target for fighting atherosclerosis and cardiovascular disease.

Authors:  Eithne M Maguire; Stuart W A Pearce; Qingzhong Xiao
Journal:  Vascul Pharmacol       Date:  2018-08-14       Impact factor: 5.773

Review 6.  Oxidative stress and macrophage foam cell formation during diabetes mellitus-induced atherogenesis: role of insulin therapy.

Authors:  Marielle Kaplan; Michael Aviram; Tony Hayek
Journal:  Pharmacol Ther       Date:  2012-08-04       Impact factor: 12.310

7.  Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2.

Authors:  Alexandra Kadl; Akshaya K Meher; Poonam R Sharma; Monica Y Lee; Amanda C Doran; Scott R Johnstone; Michael R Elliott; Florian Gruber; Jenny Han; Wenshu Chen; Thomas Kensler; Kodi S Ravichandran; Brant E Isakson; Brian R Wamhoff; Norbert Leitinger
Journal:  Circ Res       Date:  2010-07-22       Impact factor: 17.367

8.  A critical role for ABC transporters in persistent lung inflammation in the development of emphysema after smoke exposure.

Authors:  Jarrod Sonett; Monica Goldklang; Piotr Sklepkiewicz; Adam Gerber; Jordis Trischler; Tina Zelonina; Marit Westerterp; Vincent Lemaître; Yasunori Okada; Jeanine D'Armiento
Journal:  FASEB J       Date:  2018-06-15       Impact factor: 5.191

9.  Reciprocal negative cross-talk between liver X receptors (LXRs) and STAT1: effects on IFN-γ-induced inflammatory responses and LXR-dependent gene expression.

Authors:  Mónica Pascual-García; Laura Rué; Theresa León; Josep Julve; José María Carbó; Jonathan Matalonga; Herbert Auer; Antonio Celada; Joan Carles Escolà-Gil; Knut R Steffensen; Esther Pérez-Navarro; Annabel F Valledor
Journal:  J Immunol       Date:  2013-05-17       Impact factor: 5.422

10.  Attenuation of acute nitrogen mustard-induced lung injury, inflammation and fibrogenesis by a nitric oxide synthase inhibitor.

Authors:  Rama Malaviya; Alessandro Venosa; Leroy Hall; Andrew J Gow; Patrick J Sinko; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2012-09-06       Impact factor: 4.219

View more
  9 in total

1.  Macrophage activation in the lung during the progression of nitrogen mustard induced injury is associated with histone modifications and altered miRNA expression.

Authors:  Alessandro Venosa; L Cody Smith; Andrew J Gow; Helmut Zarbl; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2021-05-07       Impact factor: 4.460

Review 2.  Oxidized Phospholipids in Healthy and Diseased Lung Endothelium.

Authors:  Pratap Karki; Konstantin G Birukov
Journal:  Cells       Date:  2020-04-15       Impact factor: 6.600

Review 3.  Alveolar lipids in pulmonary disease. A review.

Authors:  Christina W Agudelo; Ghassan Samaha; Itsaso Garcia-Arcos
Journal:  Lipids Health Dis       Date:  2020-06-03       Impact factor: 3.876

Review 4.  Senescence in Pulmonary Fibrosis: Between Aging and Exposure.

Authors:  Alessandro Venosa
Journal:  Front Med (Lausanne)       Date:  2020-11-12

5.  MG53 attenuates nitrogen mustard-induced acute lung injury.

Authors:  Haichang Li; Lucia Rosas; Zhongguang Li; Zehua Bian; Xiuchun Li; Kyounghan Choi; Chuanxi Cai; Xinyu Zhou; Tao Tan; Valerie Bergdall; Bryan Whitson; Ian Davis; Jianjie Ma
Journal:  J Cell Mol Med       Date:  2022-02-24       Impact factor: 5.310

6.  Intratracheal Administration of Acyl Coenzyme A Acyltransferase-1 Inhibitor K-604 Reduces Pulmonary Inflammation Following Bleomycin-Induced Lung Injury.

Authors:  Emily R Stevenson; Melissa L Wilkinson; Elena Abramova; Changjiang Guo; Andrew J Gow
Journal:  J Pharmacol Exp Ther       Date:  2022-08-15       Impact factor: 4.402

Review 7.  Halogen exposure injury in the developing lung.

Authors:  Dylan R Addis; Adam Molyvdas; Namasivayam Ambalavanan; Sadis Matalon; Tamas Jilling
Journal:  Ann N Y Acad Sci       Date:  2020-08-01       Impact factor: 6.499

Review 8.  Androgen and Androgen Receptors as Regulators of Monocyte and Macrophage Biology in the Healthy and Diseased Lung.

Authors:  Mireya Becerra-Diaz; Mason Song; Nicola Heller
Journal:  Front Immunol       Date:  2020-08-07       Impact factor: 7.561

Review 9.  Metabolic Dysregulation in Idiopathic Pulmonary Fibrosis.

Authors:  Elena Bargagli; Rosa Metella Refini; Miriana d'Alessandro; Laura Bergantini; Paolo Cameli; Lorenza Vantaggiato; Luca Bini; Claudia Landi
Journal:  Int J Mol Sci       Date:  2020-08-07       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.